Status:
COMPLETED
Bleeding Pattern Study
Lead Sponsor:
Bayer
Conditions:
Oral Contraceptive
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer Schering Pharma AG, Germany is the sponsor of the trial...
Eligibility Criteria
Inclusion
- Healthy female volunteers aged between 18 and 40 years requiring contraception.
Exclusion
- Pregnancy or lactation.
- Any conditions that might interfere with the outcome as well as all contraindications for OC use.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
1315 Patients enrolled
Trial Details
Trial ID
NCT00302666
Start Date
June 1 2003
End Date
February 1 2005
Last Update
May 18 2009
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Eberbach, Baden-Wurttemberg, Germany, 69412
2
Höchstadt A. D. Aisch, Bavaria, Germany, 91315
3
Krumbach, Bavaria, Germany, 86381
4
Neubiberg, Bavaria, Germany, 85579